|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study 显示文摘 | DAILEY GE 3RD MOHIDEEN P FIEDOREK F T | 2002 | Clin Ther2002，24，9： | 1 |
| 2 | SLC24A5, a putative cation exchanger, affects pigmentation in zebrafish and humans显示文摘 | LAMASON R L MOHIDEEN M P K MEST J R | 2005 | Science2005，310，： | 1 |
| 3 | Mitochondrial DNA polymorphisms, its copy number change and outcome in colorectal cancer显示文摘 | Mohideen AM Dicks E Parfrey P | 2015 | BMC Res Notes2015，8，： | 1 |
| 4 | A global map of rainfed cropland areas (GMRCA) at the end of last millennium using remote sensing显示文摘 | Biradar C M Thenkabail P S Noojipady P Li Y Dheeravath V Turral H Velpuri M Gumma M K Gangalakunta O R P Cai X L Xiao X M Schull M A Alankara R D Gunasinghe S Mohideen S | | 0，，02： | 1 |
| 5 | Im provement of giycemic control, triglycerides, and HDL cholesterol levels with muraglitazar, a dual(alpha/gamma) peroxisome proliferator-activated receptor activator, in patients with type 2 diabetes inadequately controlled with mefformin monotherapy显示文摘 | KENDALL K M RUBIN C J MOHIDEEN P | 2006 | Diabetes Care2006，29，5： | 1 |
| 6 | Intravenous glargine and regular insulin have similar effects on endogenous glucose output and peripheral activation/deactivation kinetic profiles显示文摘 | Mudaliar S Mohideen P Deutsch R | 2002 | Diabetes Care2002，25，9： | 1 |
| 7 | Gridlock,an HLH gene required for assembly of the aorta in zebrafish显示文摘 | Zhong T P Rosenberg M Mohideen M A | | 0，，5459： | 1 |
| 8 | Pharmacodynamic and pharmacokinetic properties of a premixed 85/15 human insulin preparation显示文摘 | Mudaliar SD Mohideen P Baxi SC | 2001 | Clinical therapeutics2001，23，3： | 1 |
| 9 | Attainment of HbA1c goals in type 2 diabetes patients treated with muraglitazar,a novel dual(α/γ)PPAR activator:experience from 3 large placebo-controlled trials显示文摘 | Frederich R Mohideen P DePril V | 2005 | Diabetologia2005，48，1： | 1 |
| 10 | Glycemic efficacy and tolerability of muraglitazar,a novel dual(α/γ)PPAR activator,Plus metformin in patients with type 2 diabetes and inadequate glucemic control显示文摘 | Mohideen P Bancken F Rubin CJ | 2005 | Diabetologia2005，48，1： | 1 |
| 11 | Pharmacodynamic and pharmacokinetic properties of a premixed 85/15 human insulin preparation显示文摘 | Mudaliar SR Mohideen P Baxi SC | | 0，，03： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员